Fibronectin as target for tumor therapy
โ
Manuela Kaspar; Luciano Zardi; Dario Neri
๐
Article
๐
2005
๐
John Wiley and Sons
๐
French
โ 347 KB
๐ 1 views
During cancer progression, the extracellular matrix (ECM) of the tissue in which the tumor grows is extensively remodeled, both by degradation of preexisting ECM molecules and by the neosynthesis of ECM components, which in many cases are not present in the ECM of normal tissues. Fibronectin (FN), a